News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

India Ranbaxy Laboratories Says US Unit Gets Violations Notice



12/28/2009 6:55:51 AM

Bookmark and Share

Reuters -- Indian drugmaker Ranbaxy Laboratories Ltd said on Thursday its wholly-owned U.S.-based unit Ohm Laboratories Inc has received a warning letter from the U.S. Food and Drug Administration (FDA) relating to violations of good manufacturing practices.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES